The global surrogacy market size is witnessing significant growth, driven by increasing infertility rates, evolving societal norms, and advancements in assisted reproductive technologies (ART). In 2024, the market was valued at USD 194.0 million and is projected to reach USD 321.4 million by 2033, exhibiting a compound annual growth rate (CAGR) of 5.48% during the forecast period. Factors such as the rise in fertility tourism, the affordability of surrogacy services, and supportive legal frameworks across various countries are contributing to this upward trend.

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019–2024
• Forecast Years: 2025–2033 

Surrogacy Market Key Takeaways

• Market Size & Growth: The surrogacy market is projected to grow from USD 194.0 million in 2024 to USD 321.4 million by 2033, reflecting a CAGR of 5.48% during the forecast period.
• Dominant Region: North America leads the market due to supportive legal frameworks and advanced fertility treatment centres.
• Type Preference: Gestational surrogacy is preferred over traditional surrogacy due to legal and ethical considerations.
• Technological Advancements: IVF with ICSI is the most widely used technology in surrogacy procedures.
• Service Provider Trends: Fertility clinics are the primary service providers, offering comprehensive reproductive services.
• Legal Developments: Increasingly clear and supportive legal environments in various countries are facilitating market growth.
• Social Acceptance: Growing societal acceptance of surrogacy, including among LGBTQ+ couples, is contributing to market expansion.

Market Growth Factors

The surrogacy market size expansion is influenced by several key factors:

1- Impact of Infertility on Surrogacy Market Growth

The surrogacy market is experiencing significant growth, primarily driven by rising global infertility rates, with one in six adults affected. This increase is linked to various factors, including lifestyle changes, delayed childbearing, and environmental issues. The demand for surrogacy is also being propelled by a rise in medical conditions like PCOS and endometriosis and is made more accessible by advancements in assisted reproductive technologies (ART) such as IVF. Additionally, changing societal norms, greater acceptance of non-traditional family structures, and "fertility tourism" to countries with more favorable regulations are all contributing to the expansion of this market, with a notable shift towards gestational surrogacy.

2 - How Have Advancements in Assisted Reproductive Technologies (ART) Impacted the Surrogacy Market?

Advancements in Assisted Reproductive Technologies (ART) have significantly transformed the surrogacy market by boosting success rates, expanding access, and creating new ethical and regulatory challenges. Innovations such as genetic screening and AI-assisted embryo selection have improved outcomes and lowered costs, while better donor options and personalized treatments offer more flexibility. These technological strides have made it possible for single individuals, same-sex couples, and those with genetic disorders to build families, leading to a global market expansion driven by increased demand and awareness. However, this growth has also introduced ethical concerns related to commercial surrogacy and the need for standardized regulations to address issues of exploitation and ensure consistent legal frameworks worldwide.

3 - Societal Acceptance of Surrogacy

Societal acceptance of surrogacy is highly diverse globally, with attitudes ranging from strict prohibition to regulated permission, driven by a mix of cultural, religious, and legal factors. Many nations, particularly in Europe and Asia, like India and Thailand, have banned or heavily restricted commercial surrogacy due to concerns about the exploitation of vulnerable women and to uphold traditional values. In contrast, countries like the United States and Ukraine have more lenient laws, allowing for commercial arrangements. Public and governmental views are influenced by ethical concerns, the role of genetic lineage, and a growing scrutiny of "reproductive tourism." Ultimately, shifting perspectives on family and parenthood, along with the broader acceptance of assisted reproductive technologies, are gradually changing how societies view and regulate surrogacy.

Request for a sample copy of this report: 

https://www.imarcgroup.com/surrogacy-market/requestsample

Market Segmentation

By Type

• Gestational Surrogacy: In this arrangement, the surrogate carries a child conceived through IVF using the intended parents' or donors' gametes, ensuring no genetic link between the surrogate and the child.
• Traditional Surrogacy: Here, the surrogate's own egg is fertilized, making her the biological mother of the child she carries.

By Technology

• IVF with ICSI: This technique involves injecting a single sperm directly into an egg, commonly used in cases of male infertility.
• IVF without ICSI: Standard IVF procedure where eggs and sperm are combined in a lab dish to allow fertilization.
• Intrauterine Insemination (IUI): A fertility treatment that involves placing sperm directly into a woman's uterus to facilitate fertilization.

By Service Provider

• Hospitals: Medical institutions offering a range of fertility treatments, including surrogacy services.
• Fertility Clinics: Specialized centers focusing on reproductive health and providing comprehensive surrogacy solutions.
• Others: Includes independent surrogacy agencies and consultants offering various support services.

Breakup by Region

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Regional Insights

North America dominates the surrogacy market, primarily due to its advanced healthcare infrastructure, favorable legal frameworks, and high awareness levels. The United States has well-established surrogacy laws in several states, attracting both domestic and international intended parents seeking reliable and legally secure surrogacy arrangements.

Recent Developments & News

In January 2025, the Supreme Court of India announced its decision to review age restrictions stipulated in the country's surrogacy legislation. The hearing, scheduled for February 11, aims to address concerns regarding the eligibility criteria for intended parents and surrogate mothers. The court emphasized the need for a comprehensive database to prevent the repeated use of the same surrogate and to safeguard against potential exploitation, highlighting the importance of regulatory oversight in the surrogacy process.

Key Players

Bourn Hall Clinic, CARE Fertility, Circle Surrogacy & Egg Donation, Extraordinary Conceptions, Growing Generations LLC, Houston Fertility Center, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Nova IVF, Ovation Fertility, Scanfert Clinic etc.

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=5298&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)